🇺🇸 Tasigna in United States

FDA authorised Tasigna on 29 October 2007

Marketing authorisations

FDA — authorised 29 October 2007

  • Application: NDA022068
  • Marketing authorisation holder: NOVARTIS
  • Status: supplemented

FDA

  • Status: approved

Tasigna in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United States

Frequently asked questions

Is Tasigna approved in United States?

Yes. FDA authorised it on 29 October 2007; FDA has authorised it.

Who is the marketing authorisation holder for Tasigna in United States?

NOVARTIS holds the US marketing authorisation.